Although the company has made no formal announcement, we have been advised that Takeda has, in fact, completed enrollment of patients into the two pivotal Phase III clinical trials of orteronel (TAK-700) for the treatment of patients with metastatic, castration-resistant prostate cancer (mCRPC). … READ MORE …
Filed under: Drugs in development, Living with Prostate Cancer, Management, Treatment | Tagged: enrollment, orteronel, TAK-700, trial | Leave a comment »
The national rates of participation in clinical trials by cancer patients have never been particularly high. The National Cancer Institute states that, “less than 5 percent of adults diagnosed with cancer each year will get treated through enrollment in a clinical trial.” … READ MORE …
Filed under: Drugs in development, Living with Prostate Cancer, Management, Treatment | Tagged: efficiency, enrollment, post-surgery, trials | 1 Comment »
… is that (at least on a national basis) way too few cancer patients participate (for a variety of reasons). … READ MORE …
Filed under: Living with Prostate Cancer, Management, Treatment | Tagged: clinical trials, enrollment | 6 Comments »
THE "NEW" PROSTATE CANCER INFOLINK 